跳至主要内容
临床试验/JPRN-jRCT1091220162
JPRN-jRCT1091220162已完成Unknown

The effects of supplementation with an omega-6/omega-3 ratio of 4/1 and related fatty acids derived signaling in autism spectrum disorders - Efficacy of supplementation with a higher ratio of omega-6/omega-3 in autism spectrum disorders

one0 个研究点目标入组 50 人开始时间: 2014年2月10日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
one
入组人数
50

研究概览

简要总结

Impairment in behavioral and social sequence was significantly improved at the end of 16-week treatment compared to the baseline. Plasma ceruloplasmin levels were significsantly increased at the end of treatment compared to the baseline. These findings suggest that this higher ratio of omegs-6/omega-3 supplementation improved behavioral and social ompairment via up-regulation of signasling.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 6age old 至 <= 20age old(—)
性别
All

入选标准

  • Individuals who met DSM-IV criteria of autism with physicaly health

排除标准

  • Individuals who have medical or mental illness except for developmental disorders. Individuals who have usually deviated fat consumption.

研究者

发起方
one

相似试验

Efficacy of supplementation with an omega-6/omega-3... | 临床试验